METROPOLIS HEALTHCARE LIMITED Metropolis Healthcare Limited Stock
Equities
METROPOLIS
INE112L01020
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,772 INR | -3.77% |
|
+1.44% | +5.57% |
| Sales 2024 * | 11.89B 143M | Sales 2025 * | 13.58B 163M | Capitalization | 90.76B 1.09B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.35B 16.17M | Net income 2025 * | 1.83B 21.97M | EV / Sales 2024 * | 7.52 x |
| Net cash position 2024 * | 1.29B 15.47M | Net cash position 2025 * | 2.62B 31.5M | EV / Sales 2025 * | 6.49 x |
| P/E ratio 2024 * |
66.5
x | P/E ratio 2025 * |
49.4
x | Employees | 4,300 |
| Yield 2024 * |
0.54% | Yield 2025 * |
0.72% | Free-Float | 50.27% |
More Fundamentals
* Assessed data
More news
Latest transcript on Metropolis Healthcare Limited
| 1 day | -3.77% | ||
| 1 week | +1.44% | ||
| Current month | +2.79% | ||
| 1 month | +10.59% | ||
| 3 months | +10.01% | ||
| 6 months | +19.51% | ||
| Current year | +5.57% |
1 week
1 671.60
1 879.00
1 month
1 585.001 933.50
Current year
1 450.001 933.50
1 year
1 209.251 933.50
3 years
1 171.353 579.90
5 years
907.003 579.90
10 years
907.003 579.90
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 23-01-01 | |
Rakesh Agarwal
DFI | Director of Finance/CFO | - | 19-11-10 |
Nilesh Shah
PSD | President | - | 87-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 20-05-13 | |
| Director/Board Member | 44 | 07-12-31 | |
| Director/Board Member | 57 | 17-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 117 M€ | +0.21% | - | |
| 0.00% | 34 M€ | +1.75% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 1,772 | -3.77% | 348 884 |
| 24-04-24 | 1,841 | +0.60% | 824,053 |
| 24-04-23 | 1,830 | +2.26% | 745,663 |
| 24-04-22 | 1,790 | +2.87% | 263,824 |
| 24-04-19 | 1,740 | -0.01% | 336,772 |
End-of-day quote NSE India S.E., April 24, 2024
More quotes
Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.
Calendar
2024-05-13
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
1,772
INR
Average target price
1,689
INR
Spread / Average Target
-4.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.57% | 1.13B | |
| -16.65% | 8.34B | |
| +39.72% | 3.59B | |
| -32.64% | 2.75B | |
| -8.06% | 2.48B | |
| -9.58% | 2.32B | |
| -13.81% | 1.79B | |
| -18.90% | 1.54B | |
| -40.19% | 1.21B | |
| -14.72% | 992M |
- Stock Market
- Equities
- METROPOLIS Stock
